share_log

Applied UV, Inc. Announces Closing of $2.76 Million Registered Direct and Private Placement

Applied UV, Inc. Announces Closing of $2.76 Million Registered Direct and Private Placement

Applied UV, Inc. 宣佈完成276萬美元的註冊直接和私募配售
GlobeNewswire ·  04/01 23:31

NEW YORK, NY, April 01, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Applied UV, Inc. (NASDAQ: AUVI) (the "Company"), a leader in smart building technology solutions, today announced the closing of its previously announced registered direct offering and concurrent private placement with institutional investors. The Company issued shares of common stock of the Company ("Common Stock") and pre-funded warrants ("Pre-Funded Warrants") in a registered direct offering. In a concurrent private placement, the Company also issued common warrants ("Common Warrants") to the same investors. Aggregate gross proceeds to the Company from both transactions were approximately $2.76 million. The transactions closed on April 1, 2024. The transactions were priced at the market under Nasdaq rules.

紐約州紐約,2024年4月1日(GLOBE NEWSWIRE)——通過NewMediaWire,智能建築技術解決方案領域的領導者應用紫外線有限公司(納斯達克股票代碼:AUVI)(“公司”)今天宣佈結束其先前宣佈的註冊直接發行和與機構投資者的同步私募配售。公司以註冊直接發行方式發行了公司普通股(“普通股”)和預先注資的認股權證(“預融資認股權證”)。在同時進行的私募中,公司還向同一投資者發行了普通認股權證(“普通認股權證”)。公司從兩筆交易中獲得的總收益約爲276萬美元。這些交易於 2024 年 4 月 1 日結束。這些交易是根據納斯達克的規定在市場上定價的。

The transactions consisted of (i) the public sale of an aggregate of 1,726,875 shares of Common Stock (or Pre-Funded Warrants in lieu thereof) and (ii) the private placement of Common Warrants to purchase up to 518,065 shares of Common Stock at an initial exercise price of $16.00 per share. The public offering price per share of Common Stock is $1.60 (or $1.5999 for each Pre-Funded Warrant, which is equal to the public offering price per share of Common Stock to be sold in the offering minus an exercise price of $0.0001 per Pre-Funded Warrant). The Pre-Funded Warrants will be immediately exercisable and may be exercised at any time until exercised in full. The Common Warrants are exercisable immediately subject to registration and expire 5 years after the initial issuance date. The Company expects to use the net proceeds from the offering to help fund recent large orders within the Smart Building Technologies division from customers including: Siemens, Sherwin Williams and Arco Murray and other general corporate purposes.

這些交易包括(i)公開發售總計1,726,875股普通股(或取而代之的預融資認股權證),以及(ii)私募普通認股權證,以每股16.00美元的初始行使價購買多達518,065股普通股。普通股每股公開發行價格爲1.60美元(或每份預籌認股權證1.599美元,等於本次發行中出售的每股普通股的公開發行價格減去每份預先注資認股權證0.0001美元的行使價)。預先注資的認股權證可立即行使,並可隨時行使,直至全部行使。普通認股權證可在註冊後立即行使,並在首次發行之日起5年後到期。該公司預計將使用此次發行的淨收益爲智能建築技術部門最近從西門子、宣文·威廉姆斯和Arco Murray等客戶那裏訂購的大宗訂單以及其他一般公司用途提供資金。

Aegis Capital Corp. acted as the exclusive placement agent for the offerings. Sichenzia Ross Ference Carmel LLP acted as counsel to the Company for the offerings. Kaufman & Canoles, P.C. acted as counsel to the Placement Agent for the offerings.

Aegis Capital Corp. 擔任此次發行的獨家配售代理。Sichenzia Ross Ference Carmel LLP擔任該公司的發行法律顧問。Kaufman & Canoles, P.C. 擔任發行代理人的法律顧問。

The registered direct offering was being made pursuant to an effective shelf registration statement on Form S-3 (No. 333-266015) previously filed with the U.S. Securities and Exchange Commission (SEC) and declared effective by the SEC on July 12, 2022. A final prospectus supplement and accompanying prospectus describing the terms of the proposed offering has been filed with the SEC and will be available on the SEC's website located at www.sec.gov. Electronic copies of the final prospectus supplement and the accompanying prospectus may be obtained, when available, by contacting Aegis Capital Corp., Attention: Syndicate Department, 1345 Avenue of the Americas, 27th floor, New York, NY 10105, by email at syndicate@aegiscap.com, or by telephone at +1 (212) 813-1010.

本次註冊直接發行是根據先前向美國證券交易委員會(SEC)提交併由美國證券交易委員會(SEC)宣佈於2022年7月12日生效的S-3表格(編號333-266015)上的有效貨架註冊聲明進行的。描述擬議發行條款的最終招股說明書補充文件和隨附的招股說明書已向美國證券交易委員會提交,並將在美國證券交易委員會的網站上公佈,網址爲 www.sec.gov。最終招股說明書補充文件和隨附的招股說明書的電子副本(如果有)可以通過以下方式獲取:紐約州紐約10105號美洲大道1345號27樓辛迪加部,發送電子郵件至 syndicate@aegiscap.com,或致電+1 (212) 813-1010。

The offer and sale of the securities in the private placement were made in a transaction not involving a public offering and have not been registered under the Securities Act of 1933, as amended (the "Securities Act"), or applicable state securities laws. Accordingly, the securities may not be reoffered or resold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws. The securities were offered only to accredited investors. Pursuant to a registration rights agreement with the investors, the Company has agreed to file one or more registration statements with the SEC covering the resale of the Common Stock and the Shares issuable upon exercise of the pre-funded warrants and warrants.

私募證券的發行和出售是在不涉及公開發行的交易中進行的,也沒有根據經修訂的1933年《證券法》(“證券法”)或適用的州證券法進行登記。因此,除非根據有效的註冊聲明或《證券法》和此類適用的州證券法註冊要求的適用豁免,否則不得在美國再發行或轉售這些證券。這些證券僅向合格投資者發行。根據與投資者的註冊權協議,公司已同意向美國證券交易委員會提交一份或多份註冊聲明,內容涉及普通股的轉售以及行使預先注資的認股權證和認股權證後可發行的股份。

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

本新聞稿不構成出售要約或招攬買入要約,在根據任何此類州或司法管轄區的證券法進行註冊或資格認證之前,此類要約、招標或出售是非法的,則不得在任何州或司法管轄區出售這些證券。

About Applied UV, Inc.

關於應用紫外線公司

Applied UV Inc. is dedicated to developing and acquiring smart building technologies for healthcare, hospitality, commercial and municipal markets. With SteriLumen, MunnWorks, LED Supply Co., and PURO, the company has a diverse portfolio that addresses various needs in the market. Applied UV Inc. is committed to innovation and excellence in providing solutions for a healthier and smarter world. More details about Applied UV, Inc., and its subsidiaries can be found at

Applied UV Inc. 致力於爲醫療保健、酒店、商業和市政市場開發和收購智能建築技術。憑藉SteriluMen、MunnWorks、LED Supply Co. 和PURO,該公司擁有多元化的產品組合,可以滿足市場的各種需求。Applied UV Inc. 致力於創新和卓越,爲更健康、更智能的世界提供解決方案。有關Applied UV, Inc. 及其子公司的更多詳細信息,請訪問

Forward-Looking Statements

前瞻性陳述

The foregoing material may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, including without limitation statements regarding the Company's product development and business prospects, and can be identified by the use of words such as "may," "will," "expect," "project," "estimate," "anticipate," "plan," "believe," "potential," "should," "continue" or the negative versions of those words or other comparable words. Forward-looking statements are not guarantees of future actions or performance. These forward-looking statements are based on information currently available to the Company and its current plans or expectations and are subject to a number of risks and uncertainties that could significantly affect current plans. Should one or more of these risks or uncertainties materialize, or the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, performance, or achievements. Except as required by applicable law, including the security laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.

上述材料可能包含經修訂的1933年《證券法》第27A條和1934年《證券交易法》第21E條所指的 “前瞻性陳述”。前瞻性陳述包括所有不只與歷史或當前事實相關的陳述,包括但不限於有關公司產品開發和業務前景的陳述,可以通過使用 “可能”、“將”、“期望”、“項目”、“估計”、“預測”、“計劃”、“相信”、“潛力”、“應該”、“繼續” 等詞語或這些詞語或其他類似詞語的負面版本來識別。前瞻性陳述並不能保證未來的行動或業績。這些前瞻性陳述基於公司目前獲得的信息及其當前的計劃或預期,並存在許多風險和不確定性,這些風險和不確定性可能會對當前計劃產生重大影響。如果其中一項或多項風險或不確定性成爲現實,或者基本假設被證明不正確,則實際結果可能與預期、相信、估計、預期、預期或計劃的結果存在顯著差異。儘管公司認爲前瞻性陳述中反映的預期是合理的,但公司無法保證未來的業績、業績或成就。除非適用法律(包括美國證券法)要求,否則公司無意更新任何前瞻性陳述以使這些陳述與實際業績保持一致。

For Additional Company Information:
Applied UV, Inc.
Max Munn
Applied UV Founder, CEO & Director
Max.munn@applieduvinc.com

有關其他公司信息:
Applied UV, Inc.
Max Munn
應用紫外線創始人、首席執行官兼董事
Max.munn@applieduvinc.com


Investor Relations Contact:
TraDigital IR
Kevin McGrath
+1-646-418-7002
kevin@tradigitalir.com


投資者關係聯繫人:
traDigital
凱文麥格拉思
+1-646-418-7002
kevin@tradigitalir.com


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論